Tulane University Logo Tulane University, School of Medicine
Department of Psychiatry and Behavioral Sciences

An Official Site of Tulane University

MAT

Medication-Assisted Treatment (MAT)

Looking for the MAT Presentation Form? Click here.

We are pleased to announce an entirely new ECHO session that will focus on providing support to providers who are currently Medication Assisted Treatment (MAT) certified or are interested in becoming MAT certified. We understand the gap that exists between obtaining MAT certification and actually beginning to prescribe different Medication-Assisted Treatments to patients. We have assembled the very best multidisciplinary team of MAT providers available to us to help you navigate that process and serve as a resource for you as you gain the confidence and experience you will need to become an MAT prescriber.

The Opioid Use Disorder MAT ECHO session is presented by a partnership between the Tulane University School of Medicine, Department of Psychiatry and the Louisiana Department of Health, Office of Behavioral Health. Participation is free and all providers interested in learning more about treating Opioid Use Disorder (OUD) with Medication Assisted Therapy (MAT) in their practices are welcome to join.

For about Opioids Use Disorder see:

What is MAT?

Medication assisted treatment (MAT) integrates behavioral health and social services interventions with treatment using an FDA-approved medication for opioid addiction. There are three medications used in MAT: buprenorphine, naltrexone, and methadone. All have been shown to reduce cravings, illicit opioid use, and overdoses. Patients receiving medications as part of their opioid addiction treatment are 75% less likely to die because of their addiction than those not receiving medications. Integrating opioid addiction treatment into your practice as a provider is one way you can personally make a tremendous impact on our state’s opioid epidemic.

While methadone may only be given in designated addiction treatment centers overseen by trained addiction physicians, both buprenorphine and naltrexone can be prescribed by providers of any medical specialty, and in a diverse range of treatment settings. In order to prescribe buprenorphine products, providers are required to obtain a waiver from the DEA and be issued a unique DEA “X” registration number which they can receive after completing an 8 hour training course on MAT for opioid dependency for physicians, and 24 hours for PAs and Nurse Practitioners. We offer this required DATA 2000 waiver training in an online format for free.

How will Tulane University Project ECHO MAT use ECHO to provide telementoring support to Louisiana MAT providers?

Tulane University Project ECHO MAT is leveraging the ECHO model to provide telementoring support to current and future MAT providers across the state of Louisiana. Our ECHO sessions feature brief, user-driven didactic content relevant to opioid use disorders and office-based MAT, delivered by national experts in the treatment of opioid use disorders. However, at the heart of the Tulane University Project ECHO MAT is the network of physicians, physician assistants, nurses, counselors, and social workers working together to support each other in treating opioid addiction in their communities.

What topics will experts discuss in the Tulane University Project ECHO MAT sessions?

Tulane University Project ECHO MAT  will be discussing a variety of topics focusing on OUD .

How can I sign up to join the Tulane University Project ECHO MAT sessions?

If you are interested in joining our Tulane University Project ECHO on MAT, please reach out to us by either completing our Contact form or emailing our project team at projectecho at tulane dot edu for more information. We are excited to work with you!